Stockreport

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Lineage Cell Therapeutics, Inc.  (LCTX) 
PDF OpRegen® Granted Regenerative Medicine Advanced Therapy (RMAT) Designation From FDAReSonance™ (ANP1) Preclinical Results Presented at 59th Annual Inner Ear Biology Works [Read more]